ASSET PURCHASE AGREEMENT BY AND BETWEEN ACTIVATION THERAPEUTICS INC. as Seller, AND OLAREGEN THERAPEUTIX INC. as Buyer, Dated as of July 15, 2018Asset Purchase Agreement • April 23rd, 2021 • Gene Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of July 15, 2018, is made by and between, Activation Therapeutics Inc., a Delaware corporation (the “Seller”), and Olaregen Therapeutix Inc., a Delaware C Corp (the “Buyer” and/or “Olaregen”), becomes effective upon the Seller’s receipt of the total $650,000 amount due and payable pursuant to ARTICLE II, Section 2.1 paid no later than the close of business on September 16, 2018 pursuant to ARTICLE I, Section 1.3 of this Agreement.
